SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Evaluating health interventions: exploiting the potential
14 references·0 citing·46 second hop
Evaluating health interventions: exploiting the potential (2003)Evaluating health interventions: exploiti…Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? (2001)Wrong SIGN, NICE mess: is nat…Managed care and technology adoption in health care: evidence from magnetic resonance imaging (2001)Managed care and technology a…Equity and the economic evaluation of healthcare (2001)Equity and the economic evalu…The influence of economic evaluation studies on decision making. (2000)The influence of economic eva…The global challenge of health care rationing (2000)The global challenge of healt…The Global Challenge of Health Care Rationing (2000)The Global Challenge of Healt…The impact of transaction costs on the institutional structuration of collaborative academic research (1998)The impact of transaction cos…Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients (1996)Lessons from international ex…Lessons from international experience in controlling pharmaceutical expenditure III: regulating industry: Table 1 (1996)Lessons from international ex…Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors (1996)Fortnightly Review: Lessons f…Something rotten in the state of clinical and economic evaluations? (1994)Something rotten in the state…If Dissemination Is the Solution, What Is the Problem ? (1980)If Dissemination Is the Solut…Costs, Risks, and Benefits of Surgery. (1978)Costs, Risks, and Benefits of…THE COST-BENEFIT APPROACH (1974)THE COST-BENEFIT APPROACHAnarchy, State, and Utopia (1975)Cost-Effectiveness in Health and Medicine (1996)Quality of Systematic Reviews of Economic Evaluations in Health Care (2002)QALYs and the capability approach (2005)Health outcomes in economic evaluation: the QALY and utilities (2010)Anarchy, State, and Utopia (2018)The Economic Institutions of Capitalism (1987)Institutions, Institutional Change and Economic Performance (1990)Institutions, Institutional Change and Economic Performance (1991)Scientists? collaboration strategies: implications for scientific and technical human capital (2004)The Impact of Research Collaboration on Scientific Productivity (2005)International research collaboration: An emerging domain of innovation studies? (2018)A Behavioral Theory of the Firm (1964)The Art and Craft of Policy Analysis (1979)Using Social Research in Public Policy Making. (1979)The role of knowledge in the policy process (1995)Reform by the Book: What Is: Or Might Be: The Role of Curriculum Materials in Teacher Learning and Instructional Reform? (1996)Utilization of social science research knowledge in Canada (2001)Payment Restrictions for Prescription Drugs under Medicaid (1987)The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization (1990)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)Dilemmas In Regulation Of The Market For Pharmaceuticals (2003)The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals (2005)Pharmaceutical policies: effects of cap and co-payment on rational use of medicines (2015)Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. (2003)Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries: Applying a Standardized Costing Methodology (2012)UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS (2012)Cost-Benefit Analysis: Theory and Practice. (1973)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Economic Evaluations and Interventions for Children and Adolescents with Mental Health Problems (1997)Systematic review of economic evaluations and cost analyses of guideline implementation strategies (2007)A Method for Minimizing the Impact of Distributional Assumptions in Econometric Models for Duration Data (1984)Unemployment Insurance and Unemployment Spells (1990)Medical Care Costs: How Much Welfare Loss? (1992)Adoption of New Technology (2003)Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector (2006)The Adoption of Innovations by Provider Organizations in Health Care (2007)Deliberations about deliberative methods: issues in the design and evaluation of public participation processes (2003)DOES DELIBERATIVE DEMOCRACY WORK? (2005)Deliberating in the Real World (2006)Evidence-Based Policymaking: A Critique (2009)Is meta-analysis the platinum standard of evidence? (2011)The impact of heterogeneity in individual frailty on the dynamics of mortality (1979)Meta-analysis in clinical trials (1986)Norm theory: Comparing reality to its alternatives. (1986)
this work references cited by second hop

References

  • 1978Costs, Risks, and Benefits of Surgery.510 cited
  • 1980If Dissemination Is the Solution, What Is the Problem ?331 cited
  • 2000The Global Challenge of Health Care Rationing227 cited
  • 2000The influence of economic evaluation studies on decision making.201 cited
  • 2001Managed care and technology adoption in health care: evidence from magnetic resonance imaging177 cited
  • 2000The global challenge of health care rationing157 cited
  • 1998The impact of transaction costs on the institutional structuration of collaborative academic research147 cited
  • 2001Equity and the economic evaluation of healthcare141 cited
  • 1996Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients128 cited
  • 1974THE COST-BENEFIT APPROACH109 cited
  • 2001Wrong SIGN, NICE mess: is national guidance distorting allocation of resources?93 cited
  • 1996Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors76 cited
  • 1996Lessons from international experience in controlling pharmaceutical expenditure III: regulating industry: Table 168 cited
  • 1994Something rotten in the state of clinical and economic evaluations?67 cited

Cited by

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

No citing works inside the corpus for this window.